Filter Results
:
(109)
Show Results For
-
All HBS Web
(109)
- News (25)
- Research (61)
- Events (1)
- Multimedia (1)
- Faculty Publications (38)
Show Results For
-
All HBS Web
(109)
- News (25)
- Research (61)
- Events (1)
- Multimedia (1)
- Faculty Publications (38)
- 17 Jun 2019
- Blog Post
Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program
and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug development strategy that...
View Details
- 04 Sep 2018
- First Look
New Research and Ideas, September 4, 2018
moral imperatives, we study the factors that influence when individuals find solutions that fall outside of the salient options presented. In particular, we study moral insight, or the discovery of solutions, other than selecting one of...
View Details
Keywords:
Dina Gerdeman
- 25 Mar 2016
- HBS Seminar
Curtis Keith, Harvard University, Blavatnik Biomedical Accelerator
- Research Summary
Overview
In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is...
View Details
- Web
Joint Degree Programs - MBA
newest joint degree program, the MS/MBA Biotechnology: Life Sciences, is designed for students interested in growing organizations that will advance new drug discoveries or therapeutics. Learn more MBA...
View Details
- Web
Overview - MBA
relevant timeframes, opportunity-costs, rewards, and organizational behavior. Assess the potential therapeutic value of discoveries emanating from lab-discovery in the life sciences and understand ways to accelerate these View Details
- Web
Capstone - MBA
that will advance new drug discoveries and therapeutics with those equally passionate about changing the business of healthcare for the better. 2 The practicalities of business decisions meet the...
View Details
- Web
MS/MBA Biotechnology: Life Sciences - MBA
Biotechnology: Life Sciences Program at Harvard University builds upon students’ existing biotech and life sciences knowledge and equips them with the latest business and scientific insights. This empowers them to lead transformative organizations that will advance new...
View Details
- Web
Curriculum - MBA
research. Topics will include in vitro microbial discovery platforms; engineering strategies such as chimeric, humanized, and human Abs; human Fc engineering; and nanobodies, antibody drug conjugates, and...
View Details
- Web
Faculty & Advisors - MBA
valued at over $12 billion. At Underscore VC, she invested in fast growing B2B software startups, including life sciences tech products used by leading biopharma companies across the drug development cycle from R&D to commercial stages....
View Details
- Web
FAQs - MBA
biotechnology or pharmaceutical companies, who go deep into the specifics of fundamental papers and clinical trials, and thereby provide students with approaches, background, and tools that they can bring in their subsequent careers in View Details
- Web
Degrees, Certifications & Alumni Status | About
transformative organizations that will advance new drug discoveries or therapeutics. The MS/MBA: Engineering Sciences Program Grants: Master in Business Administration from Harvard Business School (HBS) and...
View Details
- Web
Curriculum - MBA
Field Course: Entrepreneurial Sales & Marketing Startups face challenges with customer acquisition at stages from customer discovery to scaling. This course examines some representative issues and tools for that context. Read More...
View Details
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
venture capital firm. Since 2002, Peter has been involved in the creation of several novel therapeutic and drug discovery platform companies. Prior to Atlas he was co-founder, executive vice president, and...
View Details
- Web
Pharmaceuticals | Baker Library | Bloomberg Center | Harvard Business School
Intellectual Property Organization (WIPO) /citations/world-intellectual-property-organization-wipo Provides IP database, statistics, and documents on various IP topics such as drug discovery and development....
View Details
- Web
Fostering Innovation in Life Sciences - Health Care
the vibrant entrepreneurial community at Harvard. GETTING LIFE-SAVING DRUGS TO MARKET is a research focus for Professor Amitabh Chandra. He examines the unique effects that economics and market factors have on the development of precision...
View Details
- 03 Oct 2018
- Blog Post
HBS Lingo 101
the Harvard Graduate School of Arts and Sciences. Together with GSAS, we offer the MS/MBA Biotechnology: Life Sciences Program. Graduates earn two degrees in two years and are prepared to grow transformative organizations that will advance new View Details
- 01 Jun 2024
- News
Quantum Leap
day quantum computing becomes a reality is the day conventional digital security ends.) They should even be able to do things that digital computers cannot do at all, like realistically modeling molecules for more efficient drug View Details
- 31 May 2023
- News
Alumni Achievement Awards 2023
Photographed by Susan Young; Edited by Julia Hanna MORE ON THE RECIPIENTS Read more about the 2023 recipients, and learn about past recipients. ALUMNI ACHIEVEMENT AWARDS SITE MORE ON THE RECIPIENTS Read more about the 2023 recipients, and learn about past recipients....
View Details
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
the hospital quickly followed their example, finding the idea compelling and practical. In the pharmaceutical industry, about 90 percent of newly developed drugs fail in the experimental stage, and thus drug...
View Details
Keywords:
by Amy Edmondson & Mark D. Cannon